Study On BG Product Marketing Strategy Of Z Company

In 2007, announced by Vice Premier of CPC Central Committee, a three-year nation-wide science campaign for Chinese medicine was launched in Beijing. The same year, during the Tenth National People's Congress, Chinese Premier said in his government work report: the government will vigorously support the development of traditional Chinese medicine and ethnic medicine, and will let traditional medicine play the role of disease prevention and treatment thoroughly. President said at the opening ceremony of the congress "to combine both Chinese and Western medicines, and to support the development of Chinese traditional pharmaceutical industry." Since antibiotics sale was regulated, proprietary Chinese medicine market began to heat up. The adverse medicine reactions and side effects of western medicines gradually make consumers realize the medicines should be taken with caution. As part of the essences of Chinese culture and the world of traditional medicine, Chinese medicine has the unique advantages in treatment, health and rehabilitation. Gynecological diseases, vaginal bleeding and multiple clinical common accounts for about 30% of the gynecological diseases and these diseases repeatedly delayed. Western medicine has no specific clinical efficacy by the use of hormones, simple hemostatic agents and surgical therapy. On treating these diseases, the unique advantages of Chinese medicine get shown.Combining the EMBA management theory study and my years of pharmaceutical sales experience in Z Company, I analyze the marketing strategy and operational thinking of gynecological hemostatic with marketing theory around the BG exclusively produced by Z Company.Firstly, the thesis overviews the development of pharmaceutical industry from a marketing point of view, and further analyzes the current situation of gynecological medicine hemostatic market; Secondly, the thesis uses SWOT to analyze the market of Z's BG, again, combining the "4P" theory of marketing, that is, from product positioning, price positioning, channel positioning and marketing positioning, these four aspects to develop marketing programs for BG; Finally,based on the market practice, improvement of the programs have been made and the market has been broadened, to ensure the success of gynecological hemostatic produced by Z Company.The results of this research is a good reference for developing marketing strategies of Gynecological bleeding drugs,and it can bring many economic and social benefits for other companies.